Sun Pharmaannounced that together with its subsidiaries, it has received final approval from USFDA for it’s various Abbreviated New Drug Applications (ANDA). Approval was received for following generic formulations:
1. Hydocodone Bitartate with Acetaminophen (APAP) tablets
2. Pamidronate disodium (Aredia) for injection USP 30 mg/ vial and 90 mg/ vial
3. Gemfibrozil tablets (Lopid ) 600 mg
4. Promethazine hydrochloride (Phenargan) tablets 12.5 mg, 25 mg and 50 mg tablets.
Source: Sun Pharma press release Here
No comments:
Post a Comment